Organisation: Lyrica

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Pfizer patent blow after UK ruling on €4.4bn pain drug

Pfizer has lost the final round in a long-running patent battle in the UK after the country’s highest court ruled against it in a case involving its €4.4bn-a-year pain drug Lyrica.

Thu, 15 Nov, 2018

Pfizer shares dip as sales top $13bn

Pfizer reported better-than-expected quarterly results, driven by lower taxes and sales of generic medicines, but revenue from its branded patent-protected medicines brought disappointment.

Wed, 03 Aug, 2016

Huge differences in drug prices at pharmacies

People have been urged to make sure they are not getting ripped off by pharmacists after a survey revealed huge variations in medicine prices.

Tue, 26 Mar, 2013

Pfizer’s profit down 19% as sales hit by generic competition

Pfizer has reported first-quarter profit fell 19% after revenue from cholesterol pill Lipitor declined because of generic competition.

Wed, 02 May, 2012